Exchange: NASDAQ·Updated 07:56 PM EDT
ALLR logo

ALLR Allarity Therapeutics Inc

$1.42
$0.01
(0.70%)
Today
Closed $1.42
$0.02
(1.41%)
After Hours
Mkt Cap$22.59M
Vol56,670.00

About ALLR

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The company is focused on development of stenoparib, a novel PARP and tankyrase inhibitor for advanced ovarian cancer patients, using its DRP technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity Therapeutics was founded by Steen Knudsen and Thomas H. Jensen in 2004 and is headquartered in Tarpon Springs, FL.
63

Bullish Sentiment

How do you feel about ALLR?

Advertisement|Remove ads.